# Pain Reduction Using NEurostimulation Study

Study · id `cardio:ct-nct05311956` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05311956](<https://clinicaltrials.gov/study/NCT05311956>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05311956

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 125 participants.

## Technical summary

Registry record NCT05311956. Randomized; quadruple masking; primary purpose treatment. Start 2022-10-24 (actual); primary completion 2026-01-28 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 125 participants (planned count; ClinicalTrials.gov record NCT05311956, source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)
- Started: 2022-10-24 (actual) (ClinicalTrials.gov record NCT05311956, source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)
- Primary completion: 2026-01-28 (actual) (ClinicalTrials.gov record NCT05311956, source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT05311956, source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05311956, source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05311956-2026-05-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Pain Reduction Using NEurostimulation Study
- Acronym: PRUNE
- Condition: End Stage Kidney Disease
- Condition: Chronic Pain
- Intervention (Device): Active tDCS
- Intervention (Device): Sham tDCS
- Lead sponsor: Weill Medical College of Cornell University
- Lead sponsor class: OTHER
- Collaborator: Metropolitan Jewish Health System
- Collaborator class: OTHER
- Collaborator: Rogosin Institute
- Collaborator class: UNKNOWN
- Collaborator: Cornell University
- Collaborator class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as the lead sponsor: Weill Medical College of Cornell University (`cardio:org-weill-medical-college-of-cornell-university`)
- Registry lists this organization as a collaborator: Cornell University (`cardio:org-cornell-university`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)

## Provenance

Content hash: 6a285ce5c69d631f884ddc53b5691d53a58438f9c3048ff412a72237d6fd903e
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
